Abstract
In the present study, we examined the effect of vasopressin on the induction of the low-molecular-weight heat shock proteins heat shock protein 27 (HSP27) and alphaB-crystallin in an aortic smooth muscle cell line, A10 cells. Vasopressin induced a time-dependent accumulation of HSP27 and alphaB-crystallin. The stimulatory effects of vasopressin were dose-dependent over the range 0.1 nmol/L to 0.1 micromol/L. The EC50 values for vasopressin were 2 (HSP27) and 4 nmol/L (alphaB-crystallin). Vasopressin induced increases in the levels of the mRNAs for HSP27 and alphaB-crystallin. 12-O-Tetradecanoylphorbol 13-acetate (TPA), a protein kinase C (PKC)-activating phorbol ester, induced an accumulation of HSP27 (EC50, 20 nmol/L) and alphaB-crystallin (EC50, 2 nmol/L). In contrast, 4alpha-phorbol 12,13-didecanoate, a non-PKC-activating phorbol ester, had no such effect. Staurosporine and calphostin C, inhibitors of PKC, significantly reduced the vasopressin-induced accumulation of HSP27 and alphaB-crystallin as well as that induced by TPA. BAPTA/AM and TMB-8, inhibitors of intracellular Ca2+ mobilization, significantly reduced the vasopressin-induced accumulation of HSP27 and alphaB-crystallin. These results strongly suggest that vasopressin stimulates the induction of HSP27 and alphaB-crystallin via PKC activation in vascular smooth muscle cells and that this effect of vasopressin is dependent on intracellular Ca2+ mobilization.
Copyright 1999 Academic Press.
MeSH terms
-
Animals
-
Blotting, Northern
-
Calcium Channel Blockers / pharmacology
-
Cell Line
-
Choline / biosynthesis
-
Crystallins / biosynthesis*
-
Crystallins / genetics
-
Egtazic Acid / analogs & derivatives
-
Egtazic Acid / pharmacology
-
Enzyme Activation
-
Enzyme Inhibitors / pharmacology
-
Gallic Acid / analogs & derivatives
-
Gallic Acid / pharmacology
-
Heating
-
Inositol Phosphates / biosynthesis
-
Intracellular Signaling Peptides and Proteins
-
Muscle, Smooth, Vascular / cytology
-
Muscle, Smooth, Vascular / enzymology
-
Muscle, Smooth, Vascular / metabolism*
-
Neomycin / pharmacology
-
Phosphatidate Phosphatase / antagonists & inhibitors
-
Propranolol / pharmacology
-
Protein Kinase C / antagonists & inhibitors
-
Protein Kinase C / metabolism*
-
Protein Serine-Threonine Kinases / biosynthesis*
-
Protein Serine-Threonine Kinases / genetics
-
Rats
-
Tetradecanoylphorbol Acetate / pharmacology
-
Type C Phospholipases / antagonists & inhibitors
-
Vasoconstrictor Agents / pharmacology*
-
Vasopressins / pharmacology*
Substances
-
Calcium Channel Blockers
-
Crystallins
-
Enzyme Inhibitors
-
Inositol Phosphates
-
Intracellular Signaling Peptides and Proteins
-
Vasoconstrictor Agents
-
Vasopressins
-
Egtazic Acid
-
8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate
-
Gallic Acid
-
Propranolol
-
MAP-kinase-activated kinase 2
-
Protein Serine-Threonine Kinases
-
Protein Kinase C
-
Phosphatidate Phosphatase
-
Type C Phospholipases
-
Neomycin
-
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid
-
Choline
-
Tetradecanoylphorbol Acetate